Pharmacogenetics of <i>CYP2A6</i>, <i>CYP2B6</i>, and <i>UGT2B7</i> in the Context of HIV Treatments in African Populations

Pharmacogenetics of <i>CYP2A6</i>, <i>CYP2B6</i>, and <i>UGT2B7</i> in the Context of HIV Treatments in African Populations

Objectives: This study focuses on identifying variations in selected CYP genes related to treatment responses in patients with HIV in African populations by investigating variant characteristics and effects in African cohorts. Design: Cytochrome P450 (CYP) 2A6, 2B6, and Uridine 5’-diphospho-glucuron...

Full description

Bibliographic Details
Main Authors:	Graeme R. Ford, Antoinette Niehaus, Fourie Joubert, Michael S. Pepper
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Journal of Personalized Medicine
Subjects:	pharmacogenetics pharmacogenomic variants Efavirenz cyptochrome P-450 enzyme system precision medicine
Online Access:	https://www.mdpi.com/2075-4426/12/12/2013

Similar Items

A Robust and Fast/Multiplex Pharmacogenetics Assay to Simultaneously Analyze 17 Clinically Relevant Genetic Polymorphisms in <i>CYP3A4</i>, <i>CYP3A5</i>, <i>CYP1A2</i>, <i>CYP2C9</i>, <i>CYP2C19</i>, <i>CYP2D6</i>, <i>ABCB1,</i> and <i>VKORC1</i> Genes
by: Camille Tron, et al.
Published: (2022-05-01)

<i>CYP3A</i> and <i>CYP2B6</i> Genotype Predicts Glucose Metabolism Disorder among HIV Patients on Long-Term Efavirenz-Based ART: A Case-Control Study
by: Wondmagegn Tamiru Tadesse, et al.
Published: (2022-06-01)

Variants in <i>COMT</i>, <i>CYP3A5</i>, <i>CYP2B6,</i> and <i>ABCG2</i> Alter Quetiapine Pharmacokinetics
by: Pablo Zubiaur, et al.
Published: (2021-09-01)

Characterization of Novel <i>CYP2D6</i> Alleles across Sub-Saharan African Populations
by: Wendy Y. Wang, et al.
Published: (2022-09-01)

Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula
by: Francesco Carano, et al.
Published: (2018-01-01)

Pathway-targeted pharmacogenomics of CYP1A2 in human liver
by: Kathrin eKlein, et al.
Published: (2010-11-01)

The Evaluation of <i>CYP2D6, CYP2C9, CYP2C19</i>, and <i>CYP2B6</i> Phenoconversion in Post-Mortem Casework: The Challenge of Forensic Toxicogenetics
by: Arianna Giorgetti, et al.
Published: (2023-05-01)

Genetic variation in the 3'-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2 and UGT2B7: potential effect on regulation by microRNA and pharmacogenomics relevance
by: Marelize eSwart, et al.
Published: (2014-06-01)

An Interdisciplinary Experience focused on Pharmacogenetics: Engaging pharmacy and physician assistant students in conversations about antiplatelet therapy with respect to CYP2C19 genotype
by: Diane M Calinski, et al.
Published: (2016-02-01)

Pharmacogenetics of Cytochrome P450 2B6 (CYP2B6): Advances on Polymorphisms, Mechanisms, and Clinical Relevance
by: Ulrich M Zanger, et al.
Published: (2013-03-01)

Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, and SLCO1B1 gene-polymorphism frequency in Russian and Nanai populations
by: Sychev DA, et al.
Published: (2017-03-01)

Application of pharmacogenetics in oncology
by: Nelly N. Miteva-Marcheva, et al.
Published: (2020-08-01)

Genetic polymorphisms of CYP2B6*6, CYP2C8*3 and CYP2D6*4 in vivax malaria patients from Brazilian Amazon
by: José Pereira de Moura Neto, et al.
Published: (2023-11-01)

Association of polymorphism of CYP2D6 and CYP2C9 genes encoding P-450 proteins of cytochrome with arterial hypertension
by: Saratsev A.V., et al.
Published: (2012-12-01)

Establishment of a Pharmacogenetics Service Focused on Optimizing Existing Pharmacogenetic Testing at a Large Academic Health Center
by: Amy L. Pasternak, et al.
Published: (2020-10-01)

Associations between Selected <i>ADRB1</i> and <i>CYP2D6</i> Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias
by: Ewa Moric-Janiszewska, et al.
Published: (2023-11-01)

Pharmacogenetic Associations Between Atazanavir/UGT1A1*28 and Efavirenz/rs3745274 (CYP2B6) Account for Specific Adverse Reactions in Chilean Patients Undergoing Antiretroviral Therapy
by: Daniela Poblete, et al.
Published: (2021-05-01)

Pharmacogenetics of schizophrenia in real clinical practice: a clinical case
by: R. F. Nasyrova, et al.
Published: (2018-12-01)

A Review of the Important Role of <i>CYP2D6</i> in Pharmacogenomics
by: Christopher Taylor, et al.
Published: (2020-10-01)

Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example
by: Kisor DF, et al.
Published: (2021-05-01)

Clinical <i>CYP2D6</i> Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy
by: Tessa A. M. Mulder, et al.
Published: (2021-02-01)

Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General Practitioners
by: Denise van der Drift, et al.
Published: (2023-09-01)

Pharmacogenetic Dose Modeling Based on CYP2C19 Allelic Phenotypes
by: Julia Carolin Stingl, et al.
Published: (2022-12-01)

The concept of gene is in crisis. Does it affect pharmacogenetics and pharmacogenomics?
by: Miriam Falkenberg, et al.
Published: (2006-09-01)

Insights into CYP2B6-mediated drug–drug interactions
by: William D. Hedrich, et al.
Published: (2016-09-01)

MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?
by: Rafael eDe La Torre, et al.
Published: (2012-11-01)

Variation in CYP2A6 Activity and Personalized Medicine
by: Julie-Anne Tanner, et al.
Published: (2017-12-01)

<i>CYP2D6</i> and <i>CYP2C19</i> Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia
by: Malcolm Forbes, et al.
Published: (2023-10-01)

CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People
by: Yuanxia Cui, et al.
Published: (2020-08-01)

Pharmacogenetics of Long-Term Outcomes of Schizophrenia Spectrum Disorders: The Functional Role of CYP2D6 and CYP2C19
by: Amrit K. Sandhu, et al.
Published: (2023-09-01)

Genetic Variation in <i>CYP2D6</i> and <i>SLC22A1</i> Affects Amlodipine Pharmacokinetics and Safety
by: Paula Soria-Chacartegui, et al.
Published: (2023-01-01)

Relevance of <i>CYP2D6</i> Gene Variants in Population Genetic Differentiation
by: Anita Stojanović Marković, et al.
Published: (2022-11-01)

A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents
by: Thomas Dodsworth, et al.
Published: (2018-07-01)

Untangling SNP Variations within <i>CYP2D6</i> Gene in Croatian Roma
by: Anita Stojanović Marković, et al.
Published: (2022-02-01)

CYP2C19 and CYP2D6 Genotypes and Metabolizer Status Distribution in a Bulgarian Psychiatric Cohort
by: Hristo Y. Ivanov, et al.
Published: (2022-07-01)

Metoprolol and <i>CYP2D6</i>: A Retrospective Cohort Study Evaluating Genotype-Based Outcomes
by: Savannah Collett, et al.
Published: (2023-02-01)

Association of CYP2C9*2 Allele with Sulphonylurea-Induced Hypoglycaemia in Type 2 Diabetes Mellitus Patients: A Pharmacogenetic Study in Pakistani Pashtun Population
by: Asif Jan, et al.
Published: (2023-08-01)

CYP2D6 Expression in Veterans Experiencing Opioid Overdose: A Postmortem Review
by: Boyle J, et al.
Published: (2020-08-01)

Pharmacogenomics of cytochrome P450 3A4 (CYP3A4): recent progress towards the missing heritability problem
by: Kathrin eKlein, et al.
Published: (2013-02-01)

Influence of <i>CYP2B6</i> Genotype on Methadone Dosage in Patients from the Methadone Maintenance Treatment (MMT) Program in Pereira, Colombia
by: Carlos Isaza, et al.
Published: (2023-04-01)